Injective and BDACS to Settle Tokenized Assets in Won-Backed KRW1

Injective has signed a memorandum of understanding with South Korean digital asset custodian BDACS to make the won-backed stablecoin KRW1 the exclusive settlement asset for real-world assets on the Injective blockchain. The deal, announced Tuesday, would let institutions trade and settle tokenized assets directly in Korean won rather than routing through US dollar stablecoins.

BDACS claims KRW1 is fully backed by Korean won reserves. The claim is untested at institutional scale, and the company has not published reserve attestations in the announcement. Minting and redemption would initially be restricted to approved institutional partners, subject to regulatory approval that does not yet exist.

The agreement is a memorandum, not a launch. It binds the parties to a plan whose legality depends on legislation still being drafted.

What would KRW1 settlement change?

If the arrangement proceeds, KRW1 becomes the sole won-denominated settlement layer for tokenized assets on Injective. For institutions, that removes a currency conversion step — today, more than 99% of stablecoin supply is dollar-denominated, meaning Korean participants typically bear FX exposure when settling on-chain.

Access, however, will be narrow at first. Only approved institutional partners can mint or redeem KRW1, and every step awaits sign-off from South Korean regulators. Retail participation is not addressed in the announcement.

Where does South Korean stablecoin law stand?

The MOU arrives as Seoul drafts rules for won-backed stablecoins under its proposed Digital Asset Basic Act. The government aims to finalize the legislation by the end of 2026 — a window of roughly two years in which the Injective-BDACS arrangement can operate only in limited form, if at all.

Lawmakers have not settled who may issue won-backed stablecoins. A July policy report by Hashed Open Research and the Solana Policy Institute urged greater flexibility in issuance and interim licensing guidance while the bill is written. The proposed law would cover stablecoin issuance, disclosures and broader market rules.

South Korea is moving in the wake of the US GENIUS Act, which created a federal framework for payment stablecoins, and the EU's Markets in Crypto-Assets Regulation, which already governs stablecoin issuers.

Meanwhile, the market is signaling demand-side caution. The country's five largest crypto exchanges recorded net stablecoin outflows for 18 consecutive months through June, according to industry data cited by Cointelegraph.

Why Injective wants a won rail

Injective is a layer-1 blockchain that has concentrated on tokenized assets. In August, its institutional services arm registered with the US Securities and Exchange Commission as a transfer agent, a status that lets it maintain ownership records and facilitate securities transfers. Its native token carries a market capitalization of roughly $887 million, according to CoinMarketCap data.

The BDACS deal extends that institutional push into Asian settlement infrastructure. The operational logic is straightforward: tokenized Korean assets settle more cleanly in won than in dollar proxies.

Yet nothing in the announcement commits to a launch date, reserve audit frequency, or issuer licensing structure — the three details institutional counterparties typically require before settlement reliance.

What to watch

The arrangement's substance depends on the Digital Asset Basic Act, due for finalization by the end of 2026. Until lawmakers resolve who can issue won-backed stablecoins, KRW1 remains a planned instrument rather than a settlement asset, and the exclusive designation on Injective is provisional by construction.